Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus
Abstract Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, leading to elevated blood sugar levels. Exogenous insulin can counteract the diminished response to insulin and effectively controlling blood glucose levels, thereby minimizing diabetes-related comp...
Saved in:
Main Authors: | Chan Yew Low, Wei Ling Gan, Su Jeat Lai, Rachel Su-May Tam, Jie Fei Tan, Stefanie Dietl, Lay Hong Chuah, Nicolas Voelcker, Athirah Bakhtiar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-024-03062-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposomal Formulations: A Recent Update
by: Surendra S. Agrawal, et al.
Published: (2024-12-01) -
Physiological and pathophysiological actions of insulin in the liver
by: Naoto Kubota, et al.
Published: (2025-02-01) -
Association Between Four Non-Insulin-Based Insulin Resistance Indices and the Risk of Post-Stroke Depression
by: Wang P, et al.
Published: (2025-01-01) -
Formulation of new drug delivery systems for insulin from natural bioactive biocompatible polymers
by: Howida A. Fetouh, et al.
Published: (2025-01-01) -
Budget impact analysis of insulin glargine vs. isophane protamine insulin treatment for patients with type-2 diabetes and severe hypoglycemia in Thailand
by: Unchalee Permsuwan, et al.
Published: (2025-01-01)